Abstract
We have set out to document the current state of legislation and guidelines on insurance and genetic testing in different European countries, and to evaluate factors which will shape future developments in this complex area. The advantage of a Multi-national Demonstration Project such as this is that it can investigate the effectiveness of practice in different socio-economic contexts, their similarities and differences. These can be evaluated in the context of local services, the degree of public awareness and perception of cancer genetic issues, and the information discussed during predictive testing counselling sessions in cancer genetic clinics.
| Original language | English |
|---|---|
| Pages (from-to) | 272-277 |
| Number of pages | 6 |
| Journal | CME Journal of Gynecologic Oncology |
| Volume | 5 |
| Issue number | 3 |
| Publication status | Published - 2000 |
Fingerprint
ASJC Scopus subject areas
- Obstetrics and Gynaecology
- Oncology
Cite this
Insurance considerations for individuals with a high risk of breast cancer in Europe : Some recommendations. / Morrison, P. J.; Steel, C. M.; Nevin, N. C.; Evans, D. G.; Eccles, D. M.; Vasen, H.; Møller, P.; Hodgson, S.; Stoppa-Lyonnet, D.; Chang-Claude, J.; Caligo, M.; Oláh, E.; Haites, N. E.
In: CME Journal of Gynecologic Oncology, Vol. 5, No. 3, 2000, p. 272-277.Research output: Article
}
TY - JOUR
T1 - Insurance considerations for individuals with a high risk of breast cancer in Europe
T2 - Some recommendations
AU - Morrison, P. J.
AU - Steel, C. M.
AU - Nevin, N. C.
AU - Evans, D. G.
AU - Eccles, D. M.
AU - Vasen, H.
AU - Møller, P.
AU - Hodgson, S.
AU - Stoppa-Lyonnet, D.
AU - Chang-Claude, J.
AU - Caligo, M.
AU - Oláh, E.
AU - Haites, N. E.
PY - 2000
Y1 - 2000
N2 - We have set out to document the current state of legislation and guidelines on insurance and genetic testing in different European countries, and to evaluate factors which will shape future developments in this complex area. The advantage of a Multi-national Demonstration Project such as this is that it can investigate the effectiveness of practice in different socio-economic contexts, their similarities and differences. These can be evaluated in the context of local services, the degree of public awareness and perception of cancer genetic issues, and the information discussed during predictive testing counselling sessions in cancer genetic clinics.
AB - We have set out to document the current state of legislation and guidelines on insurance and genetic testing in different European countries, and to evaluate factors which will shape future developments in this complex area. The advantage of a Multi-national Demonstration Project such as this is that it can investigate the effectiveness of practice in different socio-economic contexts, their similarities and differences. These can be evaluated in the context of local services, the degree of public awareness and perception of cancer genetic issues, and the information discussed during predictive testing counselling sessions in cancer genetic clinics.
KW - Genetic testing
KW - Guidelines
KW - Insurance
UR - http://www.scopus.com/inward/record.url?scp=0034520279&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034520279&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0034520279
VL - 5
SP - 272
EP - 277
JO - CME Journal of Gynecologic Oncology
JF - CME Journal of Gynecologic Oncology
SN - 1219-9087
IS - 3
ER -